K. Rajsekhar

发表

Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women

Ashutosh Kumar Singh, P. Roy, S. Gupta, 2022, Applied Health Economics and Health Policy.

Addressing the Cost Data Gap for Universal Healthcare Coverage in India: A Call to Action.

L. Guinness, S. Prinja, P. Bahuguna, 2020, Value in health regional issues.

Stakeholders' Perspective for Improved Universal Newborn Hearing Screening Uptake in Odisha, India.

Rinshu Dwivedi, S. Pati, D. Bhattacharya, 2020, Journal of tropical pediatrics.

Use of Portable Automated Auditory Brainstem Responses in Universal Neonatal Hearing Screening: A Mixed-Method Study in Odisha, India

Rinshu Dwivedi, D. Bhattacharya, K. Sahoo, 2023, Indian Journal of Pediatrics.

Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience

S. Prinja, Gaurav Jyani, Nidhi Gupta, 2021, Expert review of pharmacoeconomics & outcomes research.

Process evaluation of health system costing – Experience from CHSI study in India

L. Guinness, S. Prinja, P. Bahuguna, 2020, PloS one.

Health technology assessment in India: Reflection & future roadmap

S. Prinja, V. Gauba, K. Rajsekhar, 2020, The Indian journal of medical research.

Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India—A Model-Based Economic Analysis

P. Roy, L. Kumar, S. Prinja, 2022, JCO global oncology.

Cost of hospital services in India: a multi-site study to inform provider payment rates and Health Technology Assessment

L. Guinness, S. Prinja, P. Bahuguna, 2022, BMC Health Services Research.

Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for Clinicians.

S. Prinja, Nidhi Gupta, R. Dhiman, 2020, Journal of clinical and experimental hepatology.